Company - Corporate Actions - Earnings
Kazia Therapeutics Limited (KZIA) confirmed earnings release on September 26, 2024, Before the market for the quarter ending June 30, 2024.
...
September 25, 2024 KZIA -1.41%
Galapagos NV (GLPG) confirmed earnings release on September 26, 2024, Before the market for the quarter ending June 30, 2024.The estimated EPS is $-0.16The annoucened EPS was $0.14The estimated revenue...
September 25, 2024 GLPG 5.83%
Can-Fite Biopharma Ltd (CANF) confirmed earnings release on September 26, 2024, Before the market for the quarter ending June 30, 2024.The estimated EPS is $-0.36The estimated revenue is $100000
...
September 25, 2024 CANF -2.97%
Renalytix AI Plc (RNLX) confirmed earnings release on September 26, 2024, Before the market for the quarter ending July 01, 2024.The estimated EPS is $-0.04The estimated revenue is $800000
...
September 25, 2024 CANF -2.97%
X.T.L. Biopharmaceuticals Ltd. (XTLB) confirmed earnings release on September 26, 2024, Before the market for the quarter ending June 30, 2024.
...
September 25, 2024 XTLB 0.00%
Huize Holding Ltd (HUIZ) confirmed earnings release on September 25, 2024, Before the market for the quarter ending June 30, 2024.The estimated revenue is $36572700
...
September 25, 2024 HUIZ 0.00%
Inventiva (IVA) confirmed earnings release on September 25, 2024, Before the market for the quarter ending June 30, 2024.
...
September 25, 2024 IVA -6.49%
Genetic Technologies Ltd. (GENE) confirmed earnings release on September 25, 2024, Before the market for the quarter ending June 30, 2024.
...
September 25, 2024 IVA -6.49%
Huize Holding Ltd (HUIZ) confirmed earnings release on September 25, 2024, Before the market for the quarter ending June 30, 2024.The estimated revenue is $36572700
...
September 25, 2024 HUIZ 0.00%
Inventiva (IVA) confirmed earnings release on September 25, 2024, Before the market for the quarter ending June 30, 2024.
...
September 25, 2024 IVA -6.49%